Home  ›  LifeSign  ›  Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test

Status™ COVID-19/Flu A&B Rapid Combination Test

Regular price $550.00
Sale price $550.00 Regular price
Unit price
Save
In Stock
Rendering loop-subscriptions
  • 25 Tests per Box
  • Test type: Lateral flow immunoassay
  • Specimen type: Anterior nasal or nasopharyngeal swab specimens
  • Turnaround time: 15-20 minutes
  • FDA status: Emergency Use Authorization (EUA) Granted
  • CLIA complexity: Waived
Choose your purchase type:

Subscription Details:

  • Save 10-15% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Choose your delivery schedule:
Pickup available at PHARMALYNK WAREHOUSE

Usually ready in 4 hours

  • All orders ship the same day (Free $250+)

  • Save 10% — on auto-renew orders.

  • Wholesale Program available

Improving the quality of life.

LifeSign is a medical diagnostic company delivering high quality rapid point of care testing solutions to caregivers in critical care, physicians’ offices, schools, ships, ambulances, the workplace, criminal justice and the home. Our products are developed and manufactured under ISO, FDA cGMP, and CE mark guidelines, and marketed and supported with the highest of quality standards by LifeSign's team of Sales, Technical, and Customer Service professionals. Our mission and commitment is to improve the quality of life within our global community by providing high quality testing solutions to care providers.

FAQs

This test can detect the presence of COVID-19, influenza A, and influenza B.

A negative result could be due to an antigen level below the test's detection limit, or if the sample was collected or transported incorrectly.

A positive result doesn't rule out co-infections with other pathogens. It also doesn't identify specific influenza A subtypes or differentiate between SARS-CoV and SARS-CoV-2.

If you need to differentiate between specific strains of influenza A or SARS, you should consult with your local or state public health department.

About LifeSign
High-quality testing solutions for care providers.
LifeSign is a medical diagnostic company delivering high quality rapid point of care testing solutions to caregivers in critical care, physicians’ offices, schools, ships, ambulances, the workplace, criminal justice and the home. LifeSign's extensive line of innovative products are used worldwide for the detection of medical conditions and illnesses that include Infectious Disease, Women’s Health, and Cardiac Markers.
Shop all LifeSign